Pengfei Yu
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Genetics top 2%
- Mesenchymal stem cell research 6
- Immunology top 5%
- Immune cells in cancer 7
- Oncology top 5%
- Cancer Cells and Metastasis 7
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 6
- RNA Research and Splicing 6
-
- Genetic factors in colorectal cancer 5
- Cited by
- Cancer ResearchGeneticsImmunology
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Pengfei Yu
73 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 626
- Genetics 416
- Immunology 545
- Oncology 663
- Molecular Biology 1.2k
Countries citing papers authored by Pengfei Yu
This map shows the geographic impact of Pengfei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Yu more than expected).
Fields of papers citing papers by Pengfei Yu
This network shows the impact of papers produced by Pengfei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Yu. The network helps show where Pengfei Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengfei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 57 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 15 | |
| 12 | Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study | 2022 | 17 |
| 13 | 2022 | 23 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 14 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 11 | |
| 18 | 2017 | 12 | |
| 19 | What Makes Protein Indigestible from Tissue, Cellular and Molecular Structure Aspects? | 2013 | 9 |
| 20 | 2012 | 52 |
About Pengfei Yu
Pengfei Yu is a scholar working on Cancer Research, Immunology and Oncology, having authored 79 papers that have together received 2.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (7 papers), Immune cells in cancer (7 papers), Mesenchymal stem cell research (6 papers), Epigenetics and DNA Methylation (6 papers), RNA Research and Splicing (6 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Cancer Research (626 citations), Genetics (416 citations) and Immunology (545 citations). Pengfei Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yufang Shi, Ying Wang, Liangyu Lin, Guohong Hu, Yu Sun, Xueqian Zhuang, Fei Chen, Yin Huang, Sheng Zhong and Shu Dong XIAO. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.